Immune system cancer drugs tipped to be a $35 billion market
By Ben Hirschler LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the...
Read More »By Ben Hirschler LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the...
Read More »
(Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldman Sachs Group Inc, as the dru...
Read More »(Reuters) - Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch o...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Young adult drivers who usually get less than six hours of sleep per night are more ...
Read More »By Kerry Grens NEW YORK (Reuters Health) - People will choose larger portions of food if they are labeled as being "healthier," even...
Read More »By Gene Emery NEW YORK (Reuters Health) - A new study has confirmed that removing the tonsils and adenoids of children with obstruct...
Read More »By Stephanie Nebehay GENEVA (Reuters) - The H7N9 virus appears to have been brought under control in China largely due to restrictio...
Read More »Tunis (Reuters) - A 66-year-old Tunisian man has died from new coronavirus, a strain of a virus that emerged in the Middle East last...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Teens who have a classmate die of suicide are more likely to consider taking, or attemp...
Read More »By Ivan Oransky NEW YORK (Reuters Health) - The importance of health literacy hit home for Lisa Gualtieri when a Cambodian refugee d...
Read More »